| Literature DB >> 25667126 |
Abstract
Three ongoing challenges have arisen after the introduction of therapeutic hypothermia (TH) as standard of care for term newborns with moderate or severe perinatal asphyxia: (i) to ensure that the correct group of infants are cooled; (ii) to optimize the delivery of TH and intensive care in relation to the severity of the encephalopathy; (iii) to systematically follow up the long-term efficacy of TH using comparable outcome data between centers and countries. This review addresses the entry criteria for TH, and discusses potential issues regarding patient selection, and management of TH: cooling mild, moderate, and very severe perinatal asphyxia, cooling longer or deeper, and/or starting with a greater delay. This includes cooling of patients outside of standard trial entry criteria, such as after postnatal collapse, premature infants, those with infection, and infants with metabolic, chromosomal or surgical diagnoses in addition to perinatal asphyxia.Entities:
Keywords: Clinical trial; Follow-up; Human; Hypoxic–ischemic encephalopathy; Inclusion criteria; Therapeutic hypothermia
Mesh:
Year: 2015 PMID: 25667126 DOI: 10.1016/j.siny.2015.01.002
Source DB: PubMed Journal: Semin Fetal Neonatal Med ISSN: 1744-165X Impact factor: 3.926